Saibal Dey
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- HIV/AIDS drug development and treatment 14
- Oncology 18
- Drug Transport and Resistance Mechanisms 18
- Co-authors
- Michael M. GottesmanIra PastanSuresh V. AmbudkarMurali RamachandraChristine A. HrycynaBarry P. RosenCaroline LeeCarol Cardarelli
- Journals
- Biochemistry (6 papers)Journal of Biological Chemistry (3 papers)Biochemical Pharmacology (2 papers)Toxicology and Applied Pharmacology (2 papers)Molecular Microbiology (1 paper)
- Partner nations
- United StatesCanadaHong Kong
In The Last Decade
Saibal Dey
27 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 2.5k
- Pediatrics, Perinatology and Child Health 1.0k
- Infectious Diseases 900
- Virology 210
- Pharmacology 348
Countries citing papers authored by Saibal Dey
This map shows the geographic impact of Saibal Dey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saibal Dey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saibal Dey more than expected).
Fields of papers citing papers by Saibal Dey
This network shows the impact of papers produced by Saibal Dey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saibal Dey. The network helps show where Saibal Dey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Saibal Dey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 33 | |
| 2 | 2007 | 50 | |
| 3 | 2006 | 9 | |
| 4 | 2006 | 8 | |
| 5 | 2006 | 18 | |
| 6 | 2006 | 70 | |
| 7 | 2006 | 15 | |
| 8 | 2003 | 77 | |
| 9 | Biricodar. Vertex Pharmaceuticals. | 2002 | 2 |
| 10 | BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER Hit paper breakdown → | 1999 | 1733 |
| 11 | 1998 | 28 | |
| 12 | 1997 | 86 | |
| 13 | 1997 | 70 | |
| 14 | 1997 | 287 | |
| 15 | 1996 | 41 | |
| 16 | 1996 | 53 | |
| 17 | 1994 | 84 | |
| 18 | 1994 | 9 | |
| 19 | 1993 | 59 | |
| 20 | 1992 | 36 |
About Saibal Dey
Saibal Dey is a scholar working on Infectious Diseases, Oncology, Applied Microbiology and Biotechnology, Physiology and Pediatrics, Perinatology and Child Health, having authored 27 papers that have together received 3.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), HIV/AIDS drug development and treatment (14 papers), Pharmacological Effects and Toxicity Studies (7 papers), Trace Elements in Health (3 papers), Research on Leishmaniasis Studies (3 papers), Arsenic contamination and mitigation (3 papers), Insect and Pesticide Research (2 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Oncology (2.5k citations), Pediatrics, Perinatology and Child Health (1.0k citations), Infectious Diseases (900 citations), Virology (210 citations) and Pharmacology (348 citations). Saibal Dey has collaborated with scholars based in United States, Canada and Hong Kong. Frequent co-authors include Michael M. Gottesman, Ira Pastan, Suresh V. Ambudkar, Murali Ramachandra, Christine A. Hrycyna, Barry P. Rosen, Caroline Lee, Carol Cardarelli, Kuan‐Teh Jeang and Peter Hafkemeyer. Their work appears in journals such as Biochemistry, Journal of Biological Chemistry, Biochemical Pharmacology, Toxicology and Applied Pharmacology and Molecular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.